Dyslipidemia and other cardiovascular risk factors in a Canadian First Nation pediatric population with type 2 diabetes mellitus

Pediatric Diabetes

Volumn 8, Issue 6, 2007, Pages 384-390

  Sellers, Elizabeth A C ^a,b   Yung, Grant ^a   Dean, Heather J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b NONE   (Canada)

Author keywords

Adolescents; Children; Lipid levels; T2DM

Indexed keywords

APOLIPOPROTEIN B; GLUCOSE; HEMOGLOBIN A1C; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CANADA; CARDIOVASCULAR RISK; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SMOKING;

ADOLESCENT; CANADA; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHILD; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MALE; POPULATION GROUPS; RISK FACTORS;

EID: 36448957989     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2007.00284.x     Document Type: Article

References (31)

1. Fagot-Campagna A. Emergence of type 2 diabetes mellitus in children: epidemiological evidence. J Pediatr Endocrinol Metab 2000: 13 (Suppl. 6): 1395-1402.
2. Diabetes Education Resource for Children and Adolescents. Annual report. Winnipeg, Canada: Department of Pediatrics and Child Health, University of Manitoba, 2004.
3. Dean HJ, Young TK, Flett B, Wood-Steiman P. Screening for type-2 diabetes in aboriginal children in northern Canada. Lancet 1998: 352: 1523-1524.
4. Harris SB, Perkins BA, Whalen-Brough E. Non-insulin-dependent diabetes mellitus among First Nations children. New entity among First Nations people of north western Ontario. Can Fam Physician 1996: 42: 869-876.
5. Kannel WB, Mc Gee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979: 241: 2035-2038.
6. Kannel WB, Mc Gee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham study. Diabetes Care 1979: 2: 120-126.
7. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993: 16: 434-444.
8. Dean H, Flett B. Natural history of type 2 diabetes diagnosed in childhood: Long term follow-up in young adult years. Diabetes 2002: 51 (Suppl. 2): A24.
9. Napoli C, Glass CK, Witztum JL, Deutsch R, D'Armiento FP, Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet 1999: 354: 1234-1241.
10. Enos WF, Holmes RH, Beyer J. Landmark article, July 18, 1953: Coronary disease among United States soldiers killed in action in Korea. Preliminary report. By William F. Enos, Robert H. Holmes and James Beyer. JAMA 1986: 256: 2859-2862.
11. Mc Namara JJ, Molot MA, Stremple JF, Cutting RT. Coronary artery disease in combat casualties in Vietnam. JAMA 1971: 216: 1185-1187.
12. Strong JP, Malcom GT, Mc Mahan CA et al. Prevalence and extent of atherosclerosis in adolescents and young adults: Implications for prevention from the pathobiological determinants of atherosclerosis in Youth Study. JAMA 1999: 281: 727-735.
13. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998: 338: 1650-1656.
14. Haffner SM. Management of dyslipidemia in adults with diabetes. Diabetes Care 1998: 21: 160-178.
15. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): A prospective study. Lancet 2001: 358: 2026-2033.
16. Sniderman AD, Scantlebury T, Cianflone K. Hypertriglyceridemic hyperapoB: The unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus. Ann Intern Med 2001: 135: 447-459.
17. Taha D. Hyperlipidemia in children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2002: 15 (Suppl. 1): 505-507.
18. Fagot-Campagna A, Knowler W, Pettitt D. Type 2 diabetes in Pima Indian children: Cardiovascular risk factors at diagnosis and 10 years later. Diabetes 1998: 47 (Suppl. 3): A605.
19. Umpaichitra V, Banerji MA, Castells S. Postprandial hyperlipidemia after a fat loading test in minority adolescents with type 2 diabetes mellitus and obesity. J Pediatr Endocrinol Metab 2004: 17: 853-864.
20. Canadian Diabetes Association Clinical Practice Guideline Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2003: 27 (Suppl. 2): S1-S153.
21. Blanchard JF, Dean H, Anderson K, Wajda A, Ludwig S, Depew N. Incidence and prevalence of diabetes in children aged 0-14 years in Manitoba, Canada, 1985-1993. Diabetes Care 1997: 20: 512-515.
22. Hickman TB, Briefel RR, Carroll MD, Rifkind BM, Cleeman JI. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: Data from the Third National Health and Nutrition Examination Survey. Prev Med 1998: 27: 879-890.
23. Bachorik PS, Lovejoy KL, Carroll MD, Johnson CL. Apolipoprotein B and A1 distributions in the United States, 1988-91: Results of the National Health and Nutrition Examination Survey III (NHANES III).
24. Center for Disease Control. CDC growth charts: United States. Atlanta, GA: Center for Disease Control, 2000. Report No.: 314
25. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Pressure Group. High blood pressure in children and adults. Pediatrics 2004: 114 (2 Suppl.): 555-576.
26. Dean H. Diagnostic criteria for non-insulin dependent diabetes in youth (NIDDM-Y). Clin Pediatr 1998: 37: 67-79.
27. Sellers E, Eisenbarth G, Young TK, Dean HJ. Diabetes-associated autoantibodies in aboriginal children. Lancet 2000: 355: 1156.
28. Sniderman AD. How, when, and why to use apolipoprotein B in clinical practice. Am J Cardiol 2002: 90: 48i-54i.
29. Tremblay MS, Willms JD. Secular trends in the body mass index of Canadian children. CMAJ 2000: 163: 1429-1433.
30. Young TK, Dean HJ, Flett B, Wood-Steiman P. Childhood obesity in a population at high risk for type 2 diabetes. J Pediatr 2000: 136: 365-369.
31. Indian and Inuit Health Committee of the Canadian Pediatric Society. Tobacco use among Aboriginal children and youth. Paediatr Child Health 1999: 4: 277-281.